Nuclear Medicine Market (By Product: Diagnostics [SPECT {TC-99m, TL-201, GA-67, I-123, Others}, PET {F-18, RB-82, Others}], Therapeutics [Alpha Emitters {RA-223, Others}, Beta Emitters {I-131, Y-90, SM-153, Re-186, Lu-117, Others}, Brachytherapy {Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others}]; By Application: Diagnostics [Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Others], Therapeutics [Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumor, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global nuclear medicine market size is anticipated to around USD 16.2 billion by 2026, this market is anticipated to grow with 9.5% CAGR during the forecast time period. Increase in healthcare spending across the globe drives the demand for nuclear medicine market. Also need for advance diagnostic treatment for cancers are the other factor driving the global nuclear medicine market.

Market Dynamics

The burden of ceaseless infections or chronic diseases, for example, cancer and heart issue is on an ascent. Nuclear medicine is generally utilized for analysis or diagnosis and in addition treatment of such disorders.

Expanding occurrence of these disorders directly affects utilization of radio pharmaceuticals. According to information distributed by the World Health Organization (WHO), malignant growth is the second driving reason for death around the world and in 2015, represented 8.8 million death. This is foreseen to drive need for radiop harmaceuticals in the years to come.

Market Insights

Requirement for ahead of schedule and precise analytic strategies, combined with developing need for better treatments, is driving the market. Expanding occurrence of disease and cardiovascular issue is likewise contributing toward market development as nuclear medicine has demonstrated fairly precise in the determination and treatment of such conditions.

As per the World Health Organization (WHO) in February 2015, the quantity of new instances of Cancer is required to develop by around 70% throughout the following two decades. All around, 8.8 million individuals died from cancer growth in 2015. Cancer represents one out of each six deaths all around.

Market Segmentation

Market By Product

  • Diagnostics
    • SPECT
      • TC-99m
      • TL-201
      • GA-67
      • I-123
      • Others
    • PET
      • F-18
      • RB-82
      • Others
    • Therapeutics
      • Alpha Emitters
        • RA-223
        • Others
      • Beta Emitters
        • I-131
        • Y-90
        • SM-153
        • Re-186
        • Lu-117
        • Others
      • Brachytherapy
        • Cesium-131
        • Iodine-125
        • Palladium-103
        • Iridium-192
        • Others

Market By Application

  • Diagnostics
    • Cardiology
    • Neurology
    • Oncology
    • Thyroid
    • Lymphoma
    • Others
  • Therapeutics
    • Thyroid
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumor
    • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America initiated the market in 2018, representing an offer of over 44.0% that year. This can be ascribed to progressive healthcare infrastructure in the district, particularly in U.S. Increasing burden of disease and different cardiovascular disarranges is likewise a high effect rendering factor driving the market.

Asia Pacific is foreseen to enroll the most astounding CAGR of 10.9% during the forecast period. Demand for nuclear medicine is expanding in developing markets, for example, China and India because of rising disposable income, enhancing medicinal healthcare standards, and favourable reforms in foreign policies. China is overwhelms the Asia Pacific market and is probably going to clutch its lead position through 2026.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the nuclear medicine are Eczacibasi-Monrol, Eckert & Ziegler Group, NTP Radioisotopes SOC Ltd., Mallinckrodt Pharmaceuticals, Australian Nuclear Science & Technology Organization (ANSTO), GE Healthcare, Nordion, Inc., Jubilant Life Sciences, The Institute of Radioelements, and Bracco Imaging S.p.A.


Related Reports

Long Term Care Market By Service: ( Home Healthcare, Hospice, Nursing Care, Assisted Living Facilities ) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global long term care market size is expected to reach around 1,621 Mn by 2026 and growing at a CAGR of around 7% over the forecast period 2019 to 2026. Long term care is a term used for a variety of services, which are specially designed to meet a person's short term and long term requirement for health and personal care. This is also termed as Activities of Daily Living or ADLs, when it is served for personal care, such as dressing,

Precision Medicine Market By Technology: (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others); By Application: (Oncology, Immunology, CNS, Respiratory); By End Use: (Home care, Hospitals, Clinical Laboratories, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global precision medicine market size is expected to reach around US$ 84 Bn by 2026 and is anticipated to grow at a CAGR of around 10% in terms of revenue during the forecast period 2019 to 2026. Precision medicine is an approach to patient care that enables physicians to choose medicines that assist patients to understand their disease genetically. This can also be called custom medicine. The report provides analysis of global precis

Comprehensive Metabolic Panel (CMP) Testing Market By Disease: (Kidney Disease, Liver Disease, Diabetes, Others); By Test Type: (Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose); By End-Use: (Laboratories, PoC) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The Global Comprehensive Metabolic Panel (CMP) Testing Market size is expected to reach over US$ 18,380 Mn by 2026 and growing at a CAGR of around 7.0% from 2019 to 2026. The Comprehensive Metabolic Panel (CMP) is a commonly ordered set of 14 tests that give doctor a significant data about the present status of kidneys, electrolyte, liver and acid / base balance as well as blood sugar and blood proteins. Abnormal findings, and in particular abnormal resul

Recreational Oxygen Equipment Market By Product: Concentrators, Bar Equipment, others; By Application: Athletics/Sports, Medical, others - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global recreational oxygen equipment market is expected to grow at a CAGR of around 16.3% from 2019 to 2026 and reach the market value of around 307 Mn by 2026. Recreational Oxygen is also termed as consumer oxygen, which is used to enhance brain functioning and also to improve athletic endurance. Recreational oxygen can’t be replaced with the medical oxygen as medical oxygen is used for treatment purposes and is controlled by the FDA as a thera

Plasmid DNA Manufacturing Market (By Application: Gene Therapy, Vaccinology; By Disease: Infectious Disease, Cancer, Genetic Disorder: Research Institute , Biotech Companies; By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global plasmid DNA manufacturing market size is expected to reach over US$ 300 million by 2026 and growing at a CAGR of 20% from forecast period 2019 to 2026. There are continuous development activities carried by major players in order to test plasmid DNA applicability. Usually plasmid DNA is prepared by cesium chloride density ultracentrifugation process and it has wide applications such as c

Powered Surgical Instrument Market (By Product: Hand Piece, Power Source & Controls, Accessories; By Power Source: Battery-Powered Instruments, Pneumatic Instruments, Electric Instruments; By Application: Orthopedic Surgery, Neurosurgery, ENT Surgery, Cardiovascular Surgery, Cardiothoracic Surgery, Plastic Surgery, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global powered surgical instrument market is expected to grow at a CAGR of around 4.0% from 2019 to 2026 and reach the market value of over US$2,900 Mn by 2026. Powered surgical instrument is a market of technological instruments used to assist at the time of performing neurological and orthopedic surgery. This surgical powered instrument is categorized by product which includes high speed equipment, large bone battery/electric equipm

Cart Summary